These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36721043)

  • 1. The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
    Hergel LLF; Kielsen K; Weischendorff S; Ifversen M; Kamari-Kany N; Møller HJ; Rittig S; Grønbæk H; Müller K
    Bone Marrow Transplant; 2023 May; 58(5):587-589. PubMed ID: 36721043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lung transplantation for chronic graft-versus-host disease after hematopoietic stem cell transplantation].
    Brugière O; Bergeron A; Le Pavec J
    Rev Mal Respir; 2023 Mar; 40 Suppl 1():e69-e72. PubMed ID: 36682955
    [No Abstract]   [Full Text] [Related]  

  • 3. Durable discontinuation of systemic therapy for chronic graft-
    Pavletic SZ; Schultz KR
    Haematologica; 2023 Feb; 108(2):303-305. PubMed ID: 35615928
    [No Abstract]   [Full Text] [Related]  

  • 4. High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning.
    Halahleh KA; Ma'koseh M; Sultan I; Rimawi DH; Muradi I; Gale RP
    Acta Haematol; 2023; 146(1):88-91. PubMed ID: 36446340
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic GVHD on the move.
    Müller AMS
    Blood; 2022 Dec; 140(25):2660-2661. PubMed ID: 36548018
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic graft-versus-host disease].
    Rørvik SD; Abrahamsen IW; Myhre AE; Vo CD; Ødegaard EM; Bruserud Ø; Gedde-Dahl T; Tvedt THA
    Tidsskr Nor Laegeforen; 2023 Mar; 143(4):. PubMed ID: 36919292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A; Cheng GS
    Clin Chest Med; 2017 Dec; 38(4):607-621. PubMed ID: 29128013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease.
    De la Garza-Salazar F; Colunga-Pedraza PR; Coronado-Alejandro EU; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Gómez-Almaguer D
    Br J Haematol; 2023 May; 201(3):573-576. PubMed ID: 36859646
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT.
    Moiseev I; Ambron P; Badoglio M; Peczynski C; Basak G; Koenecke C; Schoemans H; Penack O; Peric Z
    Bone Marrow Transplant; 2023 Mar; 58(3):325-327. PubMed ID: 36446899
    [No Abstract]   [Full Text] [Related]  

  • 10. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease.
    Kloehn J; Kruchen A; Schütze K; Wustrau K; Schrum J; Müller I
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
    Arora M; Cutler CS; Jagasia MH; Pidala J; Chai X; Martin PJ; Flowers ME; Inamoto Y; Chen GL; Wood WA; Khera N; Palmer J; Duong H; Arai S; Mayer S; Pusic I; Lee SJ
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):449-55. PubMed ID: 26541363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease.
    Yanagi M; Kobayashi R; Matsushima S; Hori D; Kodama K; Suzuki D; Kobayashi K
    Pediatr Int; 2022 Jan; 64(1):e15222. PubMed ID: 35790056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia.
    Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N
    Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children.
    Azadpour S; Abdossamadi S; Ng B; Ostroumov E; Abroun S; Cuvelier GDE; Schultz KR
    Exp Hematol; 2023 May; 121():12-17. PubMed ID: 36868452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BleedHD-a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional setting.
    Warthmann A; Holbro A; Buser A; Schefer S; Degen Kellerhals S; Ravelli M; Passweg J; Stussi G; Halter J
    Bone Marrow Transplant; 2023 May; 58(5):613-615. PubMed ID: 36859715
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated ADA2 Enzyme Activity at the Onset of Chronic Graft-versus-Host Disease in Children.
    Bowers SM; Ng B; Abdossamadi S; Kariminia A; Cabral DA; Cuvelier GDE; Schultz KR; Brown KL
    Transplant Cell Ther; 2023 May; 29(5):303.e1-303.e9. PubMed ID: 36804932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Takahashi K; Katayama T; Ichikawa T; Matsuoka S; Kakinoki Y; Yoneda M; Kimura A; Koyama S; Yahara O
    Intern Med; 2023 Mar; 62(5):779-786. PubMed ID: 35945030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
    Matin A; Smith BH; Mangaonkar A; Duffy DJ; Wolf R; Alkhateeb H; Shah MV; Hogan WJ; Litzow MR
    Transplant Cell Ther; 2023 May; 29(5):324.e1-324.e6. PubMed ID: 36682472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
    Weng G; Fan Z; Xue H; Huang F; Xu N; Jin H; Yu S; Ye Z; Fan J; Xuan L; Liu Q
    Front Immunol; 2022; 13():1036403. PubMed ID: 36389692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.